{"id":"tp-61621","type":"article-newspaper","title":"Biohaven Plans Pivotal Trial for Cancer Candidate BHV-1530 by 2027","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/61621","datePublished":"2026-11-19T19:25:18.000Z","dateModified":"2026-11-19T19:25:18.000Z","language":"en","abstract":"The company announced early-stage trial data for the antibody-drug conjugate on Nov. 19.","section":"Business","references":[]}